Abstract PS5-12-02: Quantifying the value of progression-free survival in breast cancer treatment among a general population of US women
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: J. Kim, K. Spurrier, M. Jakobsson, B. Hauber, J. Doan, B. Korytowsky, J. Shafrin
Institutions: Pfizer (Sweden), Pfizer (United States)
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W7129534664
Cites:
Cited by:
Related to: